治験レーダーAI | ||
|---|---|---|
治験 NCT05199454(対象:肥満、糖尿病、心血管疾患)は募集中です。詳細は治験レーダーのタイル表示と AI 発見ツールで確認するか、ここで質問してください。 | ||
フィルター基準に一致する試験が1件見つかりました
タイル表示
Role of Adiposomes in Endothelial Dysfunction
治験(臨床試験)の詳細は主に英語で提供されています。しかし、治験レーダーAIが支援できます!「治験を説明」をクリックして、選択した言語で試験情報を表示し、議論してください。
治験番号 NCT05199454 は 介入研究 臨床試験 で、肥満、糖尿病、心血管疾患 に関するものです。現在は 募集中 で、2022年5月16日 から開始しています。60 名の参加者 の募集が計画されています。この治験は イリノイ大学シカゴ校 によって主催され、2026年12月31日 に完了予定です。ClinicalTrials.gov からの最新更新日は 2025年1月24日 です。
概要
The development of type II diabetes (T2D) is strongly associated with obesity and both are well-established risk factors for cardiovascular disease. Knowing that vascular dysfunction is an early event in the development of cardiovascular disease in obese diabetic (OB-T2D) patients, The investigators set their long-term goal to define molecular mechanisms of vascular dysfunction and corrective strategies that target these mechanisms such as physical activity and weight loss. The investigators recently discovered that human adipose tissues release extracellular vesicles (adiposomes) that are efficiently captured by endothelial cells. Adiposomes are known to carry bioactive cargos such as proteins and micro RNAs; however, their lipid content has not been studied nor has their ability to transfer their lipid cargo to endothelial cells. In the current application, the investigators propose to investigate the role of adiposomes in communicating the unhealthy milieu, mainly dysregulated lipids, to endothelial cells in OB-T2D subjects. On top of these lipid species that the investigators propose to be carried by adiposomes are glycosphingolipids (GSLs). These lipids originate from the glycosylation of ceramides, a chemical process that is upregulated in the presence of inflammation and high glucose levels. Preliminary findings showed that in endothelial cells, GSL-rich adiposomes disturb plasma membrane structure and subsequently induce endothelial dysfunction. Moreover, the investigators found that preconditioning endothelial cells with high shear stress (which is an exercise mimetic) protected endothelial cells from the detrimental effects induced by adiposomes. Therefore, the central hypothesis is that adipose tissues in OB-T2D patients release GSL-loaded adiposomes that induce vascular endothelial dysfunction. The researchers propose that exercise and weight loss interventions (bariatric surgery) will restore adipose tissue homeostasis, reduce GSL-loaded adiposomes, and subsequently alleviate vascular risk in OB-T2D patients. The investigators will test the hypotheses by pursuing the following aims: aim 1: Investigate the role of GSL-rich adiposomes in the pathogenesis of endothelial dysfunction in OB-T2D adults; aim 2: Test the effectiveness of exercise training in reducing adiposome-mediated effects on vascular function; and aim 3: Examine changes in adiposome/caveolae axis following metabolic surgery and their association with vascular function.
公式タイトル
Role of Adiposomes in Diabetes-Associated Endothelial Dysfunction and Restorative Effects of Exercise and Metabolic Surgery
疾患/病気
肥満糖尿病心血管疾患その他の研究識別子
- 2021-1113
- 1R01HL161386-01 (米国NIHの助成金/契約)
主目的
予防
割付方法
無作為化
介入モデル
並行割当
盲検化
なし(非盲検)
群(アーム)/介入
| 参加グループ/群 | 介入/治療法 |
|---|---|
実験的Exercise training Aerobic exercise training for 12 weeks, 3 times per week, 60 minutes per session. | 運動トレーニング Aerobic exercise training using a treadmill or a bike for 12 weeks, 3 times per week, 60 minutes per session. |
非介入Control (standards of care) This arm will receive brochures for healthy lifestyle recommendations. No intervention will be conducted. | 該当なし |
主要評価項目
副次評価項目
| 評価指標 | 指標の説明 | 時間枠 |
|---|---|---|
Brachial artery flow-mediated dilation (percent vasodilation) in 60 obese diabetic subjects | Brachial flow-mediated dilation will be measured using ultrasound Alpha 7. For recording, a linear probe will be positioned five centimeters above the left arm's antecubital fossa, and a 1-minute baseline imaging will be recorded. Then, a blood pressure cuff will be put around the right mid-forearm and inflated to 200 to 220 mmHg for 5 minutes. Following cuff deflation (reactive hyperemia), a video grabber will be used to record a 300-second video sequence at three frames per second for offline measurement. The greatest brachial artery diameter at baseline will be deducted from the largest mean values obtained following cuff deflation to determine relative flow mediated dilation | 4 years |
| 評価指標 | 指標の説明 | 時間枠 |
|---|---|---|
Glycosphingolipid content (ng/ml) in adiposomes from 60 obese diabetic subjects | Adiposomes isolated from adipose tissue samples will be examined for their glycosphingolipid content using mass spectrometry and the outcome will be in nanograms per milliliter (ng/ml) | 4 years |
適格基準
対象年齢
成人
試験の最低年齢
18 Years
対象性別
全て
- BMI ≥ 35 kg/m2
- Between ages 18-50 years
- Not pregnant
- Diabetic (Current use of diabetes medication or fasting glucose ≥126 mg/dL)
- Medical clearance to participate in a moderate-intensity exercise program
- Pregnant women
- Current smokers
- Currently abusing alcohol or drugs
- Chronic heart, liver, or kidney diseases, autoimmune diseases, or cancer
- Non-English speakers
- History of allergic reactions to lidocaine
責任者
Abeer M. Mohamed, 研究責任者, Assistant Professor, University of Illinois at Chicago
試験中央連絡先
連絡先: Abeer M Mohamed, MD, PhD, 312-355-8099, [email protected]
1 1カ国の場所
Illinois
University of Illinois at Chicago, Chicago, Illinois, 60612, United States
Abeer M Mohamed, MD, PhD, 連絡先, 312-355-8099, [email protected]
募集中